| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |